Evaxion Biotech A/S OverviewEvaxion Biotech A/S Selling, General & Admin
Selling, General & Admin expenses for EVAX.
Quarterly SG&A Expenses
$1.53M
↓ 10.83% YoY
As of Mar 31, 2026
Annual SG&A Expenses (TTM)
$6.32M
↓ 14.86% YoY
Trailing 12 months ending Mar 31, 2026